News
1d
MyChesCo on MSNTeleflex Study Shows 70.5% Reduction in CLABSI with Antimicrobial CVCsTeleflex Incorporated (NYSE: TFX) has announced findings from a new multinational study demonstrating the efficacy of its ...
Teleflex reports new findings from a study showing the efficacy of its Arrow chlorhexidine-impregnated central venous ...
"This facility gives what we envision our growth to be in North America in the years to come" Arrow McLaren IndyCar Team today announces its plans to relocate to a new facility fit for the future to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results